[1]
Jargin, S.V. 2023. Management of Type 2 Diabetes Mellitus with Overweight: Focus on SGLT-2 Inhibitors and GLP-1 Receptor Agonists. European Journal of Therapeutics. 25, 2 (Apr. 2023), 93–96. DOI:https://doi.org/10.5152/EurJTher.2019.18067.